Renee P Tannenbaum's Net Worth

$1.9 Million

Estimate Recalculated Nov 1, 2024 08:49AM EST

Who is Renee P Tannenbaum

Renee P Tannenbaum has an estimated net worth of $1.9 Million. This is based on reported shares across multiple companies, which include ZOGENIX, INC., ANI PHARMACEUTICALS INC, SHARPS COMPLIANCE CORP, and Cardiff Oncology, Inc..

SEC CIK

Renee P Tannenbaum's CIK is 0001543174

Past Insider Trading and Trends

2019 was Renee P Tannenbaum's most active year for acquiring shares with 5 total transactions. Renee P Tannenbaum's most active month to acquire stocks was the month of February. 2019 was Renee P Tannenbaum's most active year for disposing of shares, totalling 5 transactions. Renee P Tannenbaum's most active month to dispose stocks was the month of February. 2019 saw Renee P Tannenbaum paying a total of $609,100.00 for 68,375 shares, this is the most they've acquired in one year. In 2019 Renee P Tannenbaum cashed out on 72,878 shares for a total of $886,474.44, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ZOGENIX, INC.

Investor
Updated Mar 09, 2022
Form 4
-100.00%
-57.57K
Mar 09, 2022
Disposition
Mar 07
Form 4
-14.01%
-5.30K
$11.72
-$62.17K
Nov 30, 2021
32.57K
Sale
Nov 29
Form 4
15.21%
5.00K
$17.05
$85.25K
Jun 03, 2021
37.87K
Purchase
Jun 01
Form 4
22.00K
May 28, 2021
22.00K
Grant
May 27
Form 4
-31.33%
-15.00K
$20.74
-$311.07K
Nov 18, 2020
32.87K
Sale
Nov 17
Form 4
13.00K
Jun 29, 2020
13.00K
Grant
May 29
Form 4
13.00K
May 28, 2019
13.00K
Grant
May 22
Form 4
-25.60%
-17.50K
$30.83
-$277.37K
Mar 08, 2019
50.87K
Sale
Mar 06
Form 4
15.00K
May 24, 2018
15.00K
Grant
May 23
Form 4
20.00K
May 23, 2017
20.00K
Grant
May 23
Form 4
100.00%
5.00K
$11.00
$55.00K
Mar 20, 2017
10.00K
Purchase
Mar 16
Form 4
20.00K
Jul 15, 2016
20.00K
Grant
Jul 13
Form 4
5.00K
$15.40
$77.00K
Dec 08, 2015
5.00K
Purchase
Dec 03
Form 4
72.00K
Jun 19, 2015
72.00K
Grant
Jun 18
Form 4
75.00K
Feb 10, 2015
75.00K
Grant
Feb 06
Form 3
Feb 10, 2015
Showing 16 results

ANI PHARMACEUTICALS INC

Investor
Updated May 23, 2024
Form 4
24.22%
4.41K
May 23, 2024
22.62K
Grant
May 21
Form 4
-9.90%
-2.00K
$63.87
-$127.74K
May 17, 2024
18.21K
Sale
May 16
Form 4
51.44%
6.87K
May 24, 2023
20.21K
Grant
May 23
Form 4
13.35K
Mar 22, 2022
13.35K
Grant
Mar 19
Form 3
Mar 22, 2022
Showing 5 results

SHARPS COMPLIANCE CORP

Investor
Updated Nov 25, 2013
Form 4
37.89%
11.25K
Nov 25, 2013
40.93K
Grant
Nov 21
Form 4
61.01%
11.25K
Nov 16, 2012
29.68K
Grant
Nov 15
Form 4
118.54%
10.00K
$3.84
$38.37K
Mar 19, 2012
18.44K
Purchase
Mar 16
Form 3
Mar 01, 2012
8.44K
Showing 4 results

Cardiff Oncology, Inc.

Investor
Updated Jul 01, 2024
Form 4
30.15%
29.70K
Jul 01, 2024
128.20K
Grant
Jun 27
Form 4
39.12%
27.70K
Jun 20, 2023
98.50K
Grant
Jun 15
Form 4
10.00K
$1.72
$17.17K
Sep 19, 2022
10.00K
Purchase
Sep 15
Form 4
60.91%
26.80K
Mar 10, 2022
70.80K
Grant
Mar 09
Form 4
44.00K
Jun 14, 2021
44.00K
Grant
Jun 10
Form 3
Jun 14, 2021
Showing 6 results